Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe

NCT01424891 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Inflammation

Interventions

DRUG: Simvastatin 80 mg
DRUG: Sim10/Eze10
DRUG: Placebo

Sponsor

Heidelberg University